The secondary endpoints are : changes in the pain level between T@ and other times , intensity of the neuropathic pain component , daily opioid consumption , symptoms ( as classified by the MD Anderson Symptom Inventory ) , adverse events , and patient 's satisfaction ( measured using the Pain Treatment Satisfaction Scale ) .